PLSE (STOCKS)
Pulse Biosciences, Inc Common Stock (DE)
$25.920000
+1.550000 (+6.36%)
Prev close: $24.370000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Paul A. LaViolette
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,795.99M
- Employees
- 75
- P/E (TTM)
- -22.09
- P/B (TTM)
- 25.08
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
4
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.24 | $-0.32 | +0.0813 | +25.30% |
|
Dec 2025 (Q4)
|
$-0.26 | $-0.32 | +0.0562 | +17.77% |
|
Sep 2025 (Q3)
|
$-0.29 | $-0.32 | +0.0262 | +8.29% |
|
Jun 2025 (Q2)
|
$-0.20 | $-0.27 | +0.0652 | +24.59% |
Financial Statements
| Revenues | $751.00K |
| Cost Of Revenue | $909.00K |
| Costs And Expenses | $78.80M |
| Nonoperating Income/Loss | $3.48M |
| Selling, General, and Administrative Expenses | $30.89M |
| Research and Development | $47.00M |
| Operating Income/Loss | -$78.05M |
| Income/Loss From Continuing Operations After Tax | $71.01M |
| Income/Loss From Continuing Operations Before Tax | $72.80M |
| Net Income/Loss | -$74.57M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$74.57M |
| Net Income/Loss Available To Common Stockholders, Basic | -$74.57M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.10 |
| Basic Average Shares | 202,787,905 |
| Assets | $81.62M |
| Current Assets | $71.13M |
| Inventory | $206.00K |
| Other Current Assets | $70.92M |
| Noncurrent Assets | $10.49M |
| Fixed Assets | $1.02M |
| Other Non-current Assets | $9.48M |
| Liabilities | $15.32M |
| Current Liabilities | $9.80M |
| Accounts Payable | $2.76M |
| Wages | $2.70M |
| Other Current Liabilities | $4.33M |
| Noncurrent Liabilities | $5.53M |
| Equity | $66.30M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $66.30M |
| Liabilities And Equity | $81.62M |
| Net Cash Flow From Operating Activities | -$55.20M |
| Net Cash Flow From Operating Activities, Continuing | -$55.20M |
| Net Cash Flow From Investing Activities | -$323.00K |
| Net Cash Flow From Investing Activities, Continuing | -$323.00K |
| Net Cash Flow From Financing Activities | $4.56M |
| Net Cash Flow From Financing Activities, Continuing | $4.56M |
| Net Cash Flow | -$50.96M |
| Net Cash Flow, Continuing | -$50.96M |
| Comprehensive Income/Loss | -$74.57M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$74.57M |
| Other Comprehensive Income/Loss | -$74.57M |